Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| VERSANT VENTURE MANAGEMENT LLC | 02-08-2024 | 12-31-2023 | 7 | 388,843,408 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| CymaBay Therapeutics, Inc. | Common Stock | Liquidated | $0 | 0 | 7.06 | 3.24 | 0 | 0.00 | 12-31-2023 |
| Minerva Surgical Inc. | Common Stock | Liquidated | $0 | 0 | 0.51 | 2.27 | 0 | 0.00 | 12-31-2023 |
| RayzeBio, Inc. | Common Stock | 3 | $320,682,869 | 5,158,161 | 0.08 | 5,158,161 | +Inf | 12-31-2023 | |
| CRISPR Therapeutics AG | Common Shares | 4 | $31,209,731 | 498,558 | 0.01 | 33.20 | 0 | 0.00 | 12-31-2023 |
